Controversy Surrounds FDA Approval of New Opioid Drug Carlat Reports

Controversy Surrounds FDA Approval of New Opioid Drug

The Carlat Addiction Treatment Report, Volume 2, Number 1, January 2014
https://www.thecarlatreport.com/newsletter-issue/catrv2n1/

From The Carlat Addiction Treatment Report, January 2014, Change Management in Addiction Treatment

Issue Links: Learning Objectives | Editorial Information

Topics: Addiction | News of Note | Pharmaceutical Industry

A coalition, formed to fight what it sees as an opioid epidemic, is rallying support against the US Food and Drug Administration’s (FDA) approval of the drug Zohydro.

You can't view details of this content, please login or buy subscription here